Search Results - "Galimova, A. M."

Metformin and malignant neoplasms: a possible mechanism of antitumor action and prospects for use in practice by Kuznetsov, K. O., Safina, E. R., Gaimakova, D. V., Frolova, Ya. S., Oganesyan, I. Yu, Sadertdinova, A. G., Nazmieva, K. A., Islamgulov, A. H., Karimova, A. R., Galimova, A. M., Rizvanova, E. V.

“…Metformin is a first-line antidiabetic drug for the treatment of type 2 diabetes mellitus (DM2); its molecular target is AMP-activated protein kinase (AMPK),…”
Get full text

Metformin and malignant neoplasms: a possible mechanism of antitumor action and prospects for use in practice by Kuznetsov, K O, Safina, E R, Gaimakova, D V, Frolova, Ya S, Oganesyan, I Yu, Sadertdinova, A G, Nazmieva, K A, Islamgulov, A H, Karimova, A R, Galimova, A M, Rizvanova, E V

“…Metformin is a first-line antidiabetic drug for the treatment of type 2 diabetes mellitus (DM2); its molecular target is AMP-activated protein kinase (AMPK),…”
Get more information